Canadian Hydroxychloroquine Study Group.
A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med1991;
324: 150–154.
2.
PetriM.Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.Lupus1996;
5: S16–22.
3.
SavarinoADi TraniLDonatelliI, et al.
New insights into the antiviral effects of chloroquine. Lancet Infect Dis2006;
6: 67–69.
4.
LiuJCaoRXiM, et al.
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov2020;
6: 16.
5.
CortegianiAIngogliaGIppolitoM, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 2020; 57: 279–283, DOI: 10.1016/j.jcrc.2020.03.005.
6.
GautretPLagierJCParolaP, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Med Infect Dis 2020; 34: 101663, DOI: 10.1016/j.tmaid.2020.101663.
7.
Food and Drug Administration. Fact sheet for health care providers: Emergency Use Authorization (EUA) of hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of COVID-19 in certain hospitalized patients, https://www.fda.gov/media/136537/download (accessed 23 April 2020).
8.
MagagnoliJNarendranSPereiraF, et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv. Epub ahead of print 23 April 2020. DOI: 10.1101/2020.04.16.20065920.
9.
TangWCaoZHanM, et al. Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial. medRxiv. Epub ahead of print 7 May 2020. DOI: 10.1101/2020.04.10.20060558.
10.
SappJLAlqarawiWCiorstiM, et al. Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: a statement from the Canadian Heart Rhythm Society. Can J Cardiol. Epub ahead of print 8 April 2020. DOI: 10.1016/j.cjca.2020.04.003.